Delivery Order SPE2DB24D2105-SPE2DB25FAPNM

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,228.48, is for the delivery of 4,568,076,510 tablets of the antifungal medication Terbinafine Hydrochloride 250 mg. The contract is a firm fixed-price, non-set-aside award with a performance period ending on April 30, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Terbinafine HCL 250 mg tablets in 30-count packages. The contract has a ceiling value of $32,679.41 and a completion date of May 15, 2025. It is a firm-fixed-price contract, indicating that the agreed-upon price will not change. The contract is not set aside for any specific...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,050.91, is for the delivery of Terbinafine HCL 250 mg tablets. The contract is a firm-fixed-price delivery order with a performance period ending on May 8, 2025. This order is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,202,277 units of the medication Terbinafine HCL 250 mg tablets, with a ceiling value of $8,713.84. The contract is a firm fixed-price Delivery Order, with an ultimate completion date of May 12, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any subcontractors....
This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) to provide 4,568,056,484 units of Terbinafine HCL 250 mg tablets. The contract has a ceiling value of $21,820.64 and a period of performance through April 29, 2025. This contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency, a defense agency, for the supply of 90 tablets of the medication Terbinafine HCL 250 mg. The contract has a ceiling value of $5,181.95 and a period of performance ending on May 19, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,564.87 contract is for the delivery of 100 units of Terbinafine HCL 250 mg tablets, a medication used to treat fungal infections. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $8,773.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,187,358 units of the prescription medication Terbinafine HCL 250 mg tablets, with a final completion date of May 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,971.41 firm fixed-price delivery order is for the supply of 4,568,188,746 units of the prescription medication terbinafine hydrochloride 250 mg tablets. The contract has a performance period through May 9, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Terbinafine HCL 250 mg tablets, a generic antifungal medication, over a period ending on May 14, 2025. The award has a ceiling value of $27,321.19 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2105
    Indefinite Delivery Contract
  • SPE2DB24D2105-SPE2DB25FAPNM
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,039,746 units of terbinafine hydrochloride 250 mg tablets in 100-count bottles. The contract has a firm fixed price of $16,127.89 and a period of performance through April 28, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. This delivery order is not designated as a set-aside contract, indicating open competition. The contract aligns with the DLA's role in providing medical supplies and pharmaceuticals to support the U.S. military and other government agencies.

Generated 7/25/25, 11:06 AM